{"nct_id":"NCT00309244","title":"Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up","status":"COMPLETED","status_verified_date":"2014-10","start_date":"2006-02","start_date_type":null,"primary_completion_date":"2008-08","primary_completion_date_type":"ACTUAL","completion_date":"2008-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MNKD"]}